Alterity Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 |
|---|---|
Revenue | $3,832 |
Gross Profit | 3,769 |
EBITDA | -7,047 |
EBIT | -7,118 |
Net Income | -4,974 |
Net Change In Cash | 3,832 |
Free Cash Flow | -2,355 |
Cash | 33,158 |
Basic Shares | 12,467 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $5,438 | $4,019 | $3,916 |
Gross Profit | -113 | 5,311 | 3,804 | 3,631 |
EBITDA | -27,686 | -14,521 | -19,459 | -14,533 |
EBIT | -27,799 | -14,661 | -19,606 | -14,636 |
Net Income | -22,889 | -12,147 | -19,123 | -13,806 |
Net Change In Cash | 0 | 5,438 | 4,019 | 3,916 |
Free Cash Flow | -22,523 | -11,451 | -12,611 | -20,043 |
Cash | 37,320 | 33,158 | 12,638 | 15,773 |
Basic Shares | 17,541 | 10,661 | 6,081 | 4,046 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0 |
2024-12-31 | $0 |
2023-03-31 | $0 |
2022-12-31 | $0 |